Each month, the Geographic Health Equity Alliance (GHEA) aggregates the latest news and research related to place-based cancer control and geographic health disparities. Below you will find the latest posts, updated regularly throughout the month.
(Last updated: February 23, 2021)
Place-Based Cancer Control News and Research
- A study shows major geographic disparities in adolescents and young adults receiving or completing doses of the HPV vaccine in the United States.
General Cancer Control News and Research
- February is National Cancer Prevention Month. Learn how to prevent cancer or detect it early through CDC’s cancer prevention article.
- During California’s stay-at-home order, cervical cancer screening rates decreased approximately 80% among approximately 1.5 million women in the Kaiser Permanente Southern California (KPSC) network.
- A new study finds that more than half of cancer survivors in the United States reported having additional underlying medical conditions associated with severe COVID-19 illness.
- According to new statistics released by the International Agency for Research on Cancer, breast cancer has now surpassed lung cancer as the world’s mostly commonly-diagnosed cancer, accounting for nearly 12% of new cases each year worldwide.
- Researchers have found a way to distinguish patients who are unlikely to benefit from hormone therapy using an imaging test that measures the function of the estrogen receptors in their cancer cells.
- A new study finds that long-term aspirin use before a diagnosis of colorectal cancer may be associated with lower CRC-specific mortality.
- New research finds that between 1999 and 2018, the rate of suicide related to cancer decreased an average of 2.8% each year.
- A study on the role of diet in colorectal cancer (CRC) incidence finds evidence of an association between lower CRC risk and higher intakes of dietary fiber, calcium, and yogurt, and lower intakes of alcohol and red meat.
- National cancer registry data shows that between 2008-2012 the incidence of metastatic prostate cancers at diagnosis increased as prostate-specific antigen (PSA) screenings across U.S. states decreased.
- New research finds that Black men may have a genetic advantage when it comes to immunotherapy treatments for prostate cancer. This is due to Black men being more likely to have a type of cell on their tumors that can be targeted.
